Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells

Steroids

Volumn 65, Issue 12, 2000, Pages 903-913

  El Khissiin, Abdelhamid ^a   Journé, Fabrice ^a   Laïos, Ioanna ^a   Seo, Hye Sook ^a   Leclercq, Guy ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Antiestrogens; Estrogen receptor; Estrogens; MCF 7 cells

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; ANTIESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; CELL STRAIN MCF 7; DRUG EFFECT; ENZYME IMMUNOASSAY; ESTROGEN BINDING; HORMONAL REGULATION; HUMAN; HUMAN CELL; LIGAND BINDING; MITOGENICITY; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; RECEPTOR UPREGULATION; STIMULUS RESPONSE;

ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL NUCLEUS; CYCLOHEXIMIDE; CYTOSOL; DOWN-REGULATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, ESTROGEN; TAMOXIFEN; TIME FACTORS; TRITIUM; TUMOR CELLS, CULTURED; UP-REGULATION;

MINK CELL FOCUS-FORMING VIRUS; OXY;

EID: 0033758514     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00206-3     Document Type: Article

References (52)

1. MCF-7: The first hormone-responsive breast cancer cell line
2. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element
3. Molecular mechanisms of steroid hormone action
4. Protein synthesis is not implicated in the ligand-dependent activation of the estrogen receptor in MCF-7 cells
5. Estrogenic and antiestrogenic regulation of estrogen receptor in MCF-7 breast cancer cells: Comparison of immunocytochemical data with biochemical measurements
6. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor
7. Implication of proteasome in estrogen receptor degradation
8. Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization
9. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling
10. Up-regulation of estrogen receptors by non-steroidal antiestrogens in human breast cancer
11. Estrogenic and antiestrogenic down-regulation of estrogen receptor levels, evidence for two different mechanisms
12. Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment
13. Revision of the standards for the assessment of hormone receptors in human breast cancer
14. Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture
15. Efficient and highly selective covalent labeling of the estrogen receptor with [3H]-tamoxifen aziridine
16. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells
17. A one minute pulse of estradiol to MCF-7 breast cancer cells changes estrogen receptor binding properties and commits cells to induce estrogenic responses
18. Exchange of bound estrogens and antiestrogens in MCF-7 cells: Evidence for ligand-induced stable configurations of the estrogen receptor
19. Antiestrogenic activity of two 11β-estradiol derivatives on MCF-7 breast cancer cells
20. Length increase of the side chain of idoxifene does not improve its antagonistic potency in breast cancer cell lines
21. Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation
22. Proteasome-dependent degradation of the human estrogen receptor
23. Human estrogen receptor transcriptional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
24. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor
25. Molecular basis of agonism and antagonism in the estrogen receptor
26. Steroid hormones and temperature induce changes of binding parameters of their receptors in intact cells
27. Ubiquitination of the rat uterine estrogen receptor: Dependence on estradiol
28. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells - Relationship between processing and estrogenicity
29. Regulation of estrogen receptor levels by ligand-induced compound(s) in MCF-7 cells
30. Expression of estrogen receptor and its messenger ribonucleic acid in MCF-7 cell line; multiparametric analysis of its processing and regulation by estrogen
31. Identification of immunoassayable estrogen receptor lacking hormone binding ability in tamoxifen-treated rat uterus
32. Estrogen receptor hormone binding activity is regulated by phosphorylation-dephosphorylation of the receptor
33. 2+-calmodulin in the activation of hormone binding sites
34. Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding
35. In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor
36. Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation
37. Receptor interconversion model of hormone action - 1. ATP-mediated conversion of estrogen receptors from a high to lower affinity state and its relationship to antiestrogen action
38. Receptor interconversion model of hormone action - II. Nucleotide-mediated conversion of estrogen receptors from nonsteroid binding to the lower affinity binding state
39. Receptor interconversion model of hormone action - 1. Purification of a factor involved in conferring estradiol binding properties to the estrogen receptor
40. Receptor interconversion model of hormone action - 2. Requirement of both kinase and phosphatase activities for conferring estrogen binding activity to the estrogen receptor
41. Effect of ATP on the regulation of the steroid binding activity of the oestradiol receptor
42. Intracellular calcium and breast cancer cell growth and differentiation
43. Decrease of hormone binding capacity of estrogen receptor by calcium
44. Modulatory effect of nonesterified fatty acids on structure and binding characteristics of estrogen receptor from MCF-7 human breast cancer cells
45. Effects of 12-0-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells
46. DNA allosterically modulates the steroid binding domain of estrogen receptor
47. Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression
48. Tamoxifen-induced estrogen receptor up-regulation in mammary tumor cells is not related to growth inhibition (1997)
49. Discrepancies between antibody (EIA) and saturation analysis of estrogen receptor content in breast tumor samples
50. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences
51. Determination of oestrogen receptors by enzyme immunoassays
52. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay